Romandini, A.; Baldassarre, D.; Genovese, S.; Capri, S.; Pompilio, G.; Scatigna, M.; Werba, J.P.
Atherogenic Dyslipidemias: Unmet Needs and the Therapeutic Potential of Emerging and Novel Approaches and Drugs. Pharmaceuticals 2023, 16, 176.
https://doi.org/10.3390/ph16020176
AMA Style
Romandini A, Baldassarre D, Genovese S, Capri S, Pompilio G, Scatigna M, Werba JP.
Atherogenic Dyslipidemias: Unmet Needs and the Therapeutic Potential of Emerging and Novel Approaches and Drugs. Pharmaceuticals. 2023; 16(2):176.
https://doi.org/10.3390/ph16020176
Chicago/Turabian Style
Romandini, Alessandra, Damiano Baldassarre, Stefano Genovese, Stefano Capri, Giulio Pompilio, Marco Scatigna, and José Pablo Werba.
2023. "Atherogenic Dyslipidemias: Unmet Needs and the Therapeutic Potential of Emerging and Novel Approaches and Drugs" Pharmaceuticals 16, no. 2: 176.
https://doi.org/10.3390/ph16020176
APA Style
Romandini, A., Baldassarre, D., Genovese, S., Capri, S., Pompilio, G., Scatigna, M., & Werba, J. P.
(2023). Atherogenic Dyslipidemias: Unmet Needs and the Therapeutic Potential of Emerging and Novel Approaches and Drugs. Pharmaceuticals, 16(2), 176.
https://doi.org/10.3390/ph16020176